Services

• Speciality solutions
• Bottleneck solutions
• Available studies
• One-stop-shop for metabolism

Welcome to SBW/novamass

Background

Novamass is a part of SBW Corporation performing ADME studies for drug discovery and development companies. SBW/novamass core competencies are studies on in vitro drug metabolism, CYP related drug-drug interactions and permeation. Besides ADME studies, novamass also provides tailor-made problem solving based on LC/MS and NMR techniques (custom analysis) for biopharmaceutical and chemical industry, and natural product analysis.

Mission statement

Our mission is to reduce time-to-market and cost-of-development of drugs by helping our customers • to understand the nature of their lead molecules • to choose competent drug candidates timely and • improving success rate in the development

Providing “M” for ADME

We are the world’s leading expert in drug metabolism. We provide our customers with problem solving intelligence in: • Metabolic profiling • Metabolite identification • Drug interaction studies and • Other ADME* studies

Your benefit from being SBW/novamass customer

• Study methods optimised specifically for their molecule(s)
• Real drug molecules used as reference compounds in studies
• Superior efficiency and detection sensitivity by UPLC/TOF-MS in metabolite profiling
• Scientifically high quality predictions
• Detailed expert reports and conclusions
• Free consultation for study start-up
• Seamless link with various computational platforms for ADME, bioactivity and toxicity predictions and rational drug design

Please follow this link to retrieve a brochure of SBW/novamass knowledge and platforms